63 related articles for article (PubMed ID: 15525489)
1. [Fli1 haploinsufficiency underlies Paris-Trousseau thrombopenia].
Raslova H; Favier R; Albagli O; Vainchenker W
Med Sci (Paris); 2004 Nov; 20(11):962-4. PubMed ID: 15525489
[No Abstract] [Full Text] [Related]
2. FLI1 monoallelic expression combined with its hemizygous loss underlies Paris-Trousseau/Jacobsen thrombopenia.
Raslova H; Komura E; Le Couédic JP; Larbret F; Debili N; Feunteun J; Danos O; Albagli O; Vainchenker W; Favier R
J Clin Invest; 2004 Jul; 114(1):77-84. PubMed ID: 15232614
[TBL] [Abstract][Full Text] [Related]
3. Lonely in Paris: when one gene copy isn't enough.
Shivdasani RA
J Clin Invest; 2004 Jul; 114(1):17-9. PubMed ID: 15232606
[TBL] [Abstract][Full Text] [Related]
4. Fli-1 is required for murine vascular and megakaryocytic development and is hemizygously deleted in patients with thrombocytopenia.
Hart A; Melet F; Grossfeld P; Chien K; Jones C; Tunnacliffe A; Favier R; Bernstein A
Immunity; 2000 Aug; 13(2):167-77. PubMed ID: 10981960
[TBL] [Abstract][Full Text] [Related]
5. Paris-Trousseau syndrome : clinical, hematological, molecular data of ten new cases.
Favier R; Jondeau K; Boutard P; Grossfeld P; Reinert P; Jones C; Bertoni F; Cramer EM
Thromb Haemost; 2003 Nov; 90(5):893-7. PubMed ID: 14597985
[TBL] [Abstract][Full Text] [Related]
6. Extending knowledge on inherited platelet disorders associated with thrombocytopenia.
Hayward CP
Thromb Haemost; 2003 Nov; 90(5):770-1. PubMed ID: 14597968
[No Abstract] [Full Text] [Related]
7. Suppression of the Ewing's sarcoma phenotype by FLI1/ERF repressor hybrids.
Athanasiou M; LeGallic L; Watson DK; Blair DG; Mavrothalassitis G
Cancer Gene Ther; 2000 Aug; 7(8):1188-95. PubMed ID: 10975680
[TBL] [Abstract][Full Text] [Related]
8. [Fli-1 (Friend leukemia integration 1). Oncogene].
Bull Cancer; 1998 Oct; 85(10):830. PubMed ID: 9867365
[No Abstract] [Full Text] [Related]
9. FLI1 and EWS-FLI1 function as ternary complex factors and ELK1 and SAP1a function as ternary and quaternary complex factors on the Egr1 promoter serum response elements.
Watson DK; Robinson L; Hodge DR; Kola I; Papas TS; Seth A
Oncogene; 1997 Jan; 14(2):213-21. PubMed ID: 9010223
[TBL] [Abstract][Full Text] [Related]
10. EWS-Fli1 antisense oligodeoxynucleotide inhibits proliferation of human Ewing's sarcoma and primitive neuroectodermal tumor cells.
Tanaka K; Iwakuma T; Harimaya K; Sato H; Iwamoto Y
J Clin Invest; 1997 Jan; 99(2):239-47. PubMed ID: 9005992
[TBL] [Abstract][Full Text] [Related]
11. The Fli-1 proto-oncogene, involved in erythroleukemia and Ewing's sarcoma, encodes a transcriptional activator with DNA-binding specificities distinct from other Ets family members.
Zhang L; Lemarchandel V; Romeo PH; Ben-David Y; Greer P; Bernstein A
Oncogene; 1993 Jun; 8(6):1621-30. PubMed ID: 8502483
[TBL] [Abstract][Full Text] [Related]
12. [Analysis of expression of ets-1 and fli-1 proto-oncogenes in murine embryonic stem cells, induced to differentiation by retinoic acid].
Iakubovich EI; Evtushenko VI
Mol Biol (Mosk); 1999; 33(5):861-5. PubMed ID: 10579191
[No Abstract] [Full Text] [Related]
13. EWS-FLI1 target genes recovered from Ewing's sarcoma chromatin.
Siligan C; Ban J; Bachmaier R; Spahn L; Kreppel M; Schaefer KL; Poremba C; Aryee DN; Kovar H
Oncogene; 2005 Apr; 24(15):2512-24. PubMed ID: 15735734
[TBL] [Abstract][Full Text] [Related]
14. Paris-Trousseau thrombocytopenia is phenocopied by the autosomal recessive inheritance of a DNA-binding domain mutation in FLI1.
Stevenson WS; Rabbolini DJ; Beutler L; Chen Q; Gabrielli S; Mackay JP; Brighton TA; Ward CM; Morel-Kopp MC
Blood; 2015 Oct; 126(17):2027-30. PubMed ID: 26316623
[TBL] [Abstract][Full Text] [Related]
15. EWS/FLI-1 antagonists induce growth inhibition of Ewing tumor cells in vitro.
Kovar H; Aryee DN; Jug G; Henöckl C; Schemper M; Delattre O; Thomas G; Gadner H
Cell Growth Differ; 1996 Apr; 7(4):429-37. PubMed ID: 9052984
[TBL] [Abstract][Full Text] [Related]
16. Differential transactivation by alternative EWS-FLI1 fusion proteins correlates with clinical heterogeneity in Ewing's sarcoma.
Lin PP; Brody RI; Hamelin AC; Bradner JE; Healey JH; Ladanyi M
Cancer Res; 1999 Apr; 59(7):1428-32. PubMed ID: 10197607
[TBL] [Abstract][Full Text] [Related]
17. Downregulation and forced expression of EWS-Fli1 fusion gene results in changes in the expression of G(1)regulatory genes.
Matsumoto Y; Tanaka K; Nakatani F; Matsunobu T; Matsuda S; Iwamoto Y
Br J Cancer; 2001 Mar; 84(6):768-75. PubMed ID: 11259090
[TBL] [Abstract][Full Text] [Related]
18. Biphenotypic sarcomas with myogenic and neural differentiation express the Ewing's sarcoma EWS/FLI1 fusion gene.
Sorensen PH; Shimada H; Liu XF; Lim JF; Thomas G; Triche TJ
Cancer Res; 1995 Mar; 55(6):1385-92. PubMed ID: 7882340
[TBL] [Abstract][Full Text] [Related]
19. Multiple domains mediate transformation by the Ewing's sarcoma EWS/FLI-1 fusion gene.
Lessnick SL; Braun BS; Denny CT; May WA
Oncogene; 1995 Feb; 10(3):423-31. PubMed ID: 7845667
[TBL] [Abstract][Full Text] [Related]
20. Fli-1b is generated by usage of differential splicing and alternative promoter.
Dhulipala PD; Lee L; Rao VN; Reddy ES
Oncogene; 1998 Sep; 17(9):1149-57. PubMed ID: 9764825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
